Compound Detail
CHEMBL416146
ETORICOXIB 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL416146 |
| Name | ETORICOXIB |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | MNJVRJDLRVPLFE-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
8
Targets
27
Activities
2
Assay Types
18
PK Parameters
20
Publications
4
Known Names
15
Indications
1
Mechanisms
Molecular Properties
358.9
MW (Da)
4.18
ALogP
4
HBA
0
HBD
59.9
PSA (Ų)
0.70
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2002 |
| Availability | Unknown |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Cyclooxygenase-2 inhibitor | INHIBITOR | Prostaglandin G/H synthase 2 | ✓ | ✓ |
Indications
Rheumatic Diseases Arthritis, Rheumatoid Dysmenorrhea Low Back Pain Osteoarthritis Osteoarthritis, Knee Pain Spondylitis, Ankylosing Toothache Wounds and Injuries Bone Neoplasms HIV Infections Prostatic Neoplasms, Castration-Resistant Melanoma Tuberculosis
ATC Classification
M01AH05
etoricoxib
Level 1: MUSCULO-SKELETAL SYSTEM
Level 2: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
Activity Summary
IC50 26 meas. best 7.16
Ki 1 meas. best 7.16
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Prostaglandin G/H synthase 2 CHEMBL230 | IC50 | 7.16 | 6.325 | 70.0 | 16 |
| Prostaglandin G/H synthase 2 CHEMBL230 | Ki | 7.16 | 7.16 | 69.0 | 1 |
| Prostaglandin G/H synthase 2 CHEMBL4102 | IC50 | 6.64 | 6.64 | 230.0 | 1 |
| Mitogen-activated protein kinase 14 CHEMBL260 | IC50 | 6.28 | 6.28 | 530.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 5.96 | 5.96 | 1100.0 | 1 |
| Blood CHEMBL613416 | IC50 | 5.96 | 5.96 | 1100.0 | 1 |
| Prostaglandin G/H synthase 1 CHEMBL221 | IC50 | 4.92 | 4.3167 | 12000.0 | 3 |
| Bile salt export pump CHEMBL6020 | IC50 | 4.35 | 4.31 | 45000.0 | 2 |
| ATP-binding cassette sub-family C member 4 CHEMBL1743128 | IC50 | 4.28 | 4.28 | 53000.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 1656.0 | ng.hr.mL-1 | Rattus norvegicus |
| CL | 0.79 | mL.min-1.kg-1 | Homo sapiens |
| CL | 41.3 | mL.min-1.kg-1 | Mus musculus |
| Cmax | 30000.0 | nM | Rattus norvegicus |
| Cmax | 1189.91 | nM | Rattus norvegicus |
| Fu | 0.081 | - | Homo sapiens |
| Fu | 0.114 | - | Homo sapiens |
| MRT | 32.0 | hr | Homo sapiens |
| T1/2 | 26.0 | hr | Homo sapiens |
| T1/2 | 3.067 | hr | Homo sapiens |
| T1/2 | 0.8967 | hr | Mus musculus |
| T1/2 | 6.183 | hr | Homo sapiens |
| T1/2 | 0.4867 | hr | Mus musculus |
| T1/2 | 0.78 | hr | Mus musculus |
| T1/2 | 6.1 | hr | Homo sapiens |
| T1/2 | 2.0 | hr | Rattus norvegicus |
| Tmax | 0.3 | hr | Rattus norvegicus |
| Tmax | 0.25 | hr | Mus musculus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine